Home Cart Sign in  
Chemical Structure| 1228088-30-9 Chemical Structure| 1228088-30-9

Structure of Balovaptan
CAS No.: 1228088-30-9

Chemical Structure| 1228088-30-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Balovaptan is a highly potent and selective brain-penetrant vasopressin 1a (hV1a) receptor antagonist, with Kis of 1 and 39 nM for human (hV1a) and mouse (mV1a) receptors, and is used for the research of autism.

Synonyms: RG7314

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Balovaptan

CAS No. :1228088-30-9
Formula : C22H24ClN5O
M.W : 409.91
SMILES Code : CN1CC2=CC(Cl)=CC=C2N3C(C1)=NN=C3[C@]4(CC[C@H](OC5=CC=CC=N5)CC4)[H]
Synonyms :
RG7314
MDL No. :MFCD31706224
InChI Key :GMPZPHGHNDMRKL-UHFFFAOYSA-N
Pubchem ID :46200932

Safety of Balovaptan

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Balovaptan

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02901431 Autism Spectrum Disorder Phase 2 Recruiting April 18, 2019 -
NCT03586726 Healthy Volunteers Phase 1 Active, not recruiting November 15, 2018 Netherlands ... More >> Pra International Group B.V Groningen, Netherlands, 9728 NZ Less <<
NCT03504917 Autism Spectrum Disorder Phase 3 Recruiting March 31, 2023 -
NCT03579719 Healthy Volunteers Phase 1 Recruiting November 10, 2018 Netherlands ... More >> Pra International Group B.V Recruiting Groningen, Netherlands, 9728 NZ Less <<
NCT03764449 Healthy Volunteers Phase 1 Not yet recruiting March 20, 2019 Netherlands ... More >> Pra International Group B.V Not yet recruiting Groningen, Netherlands, 9728 NZ Less <<
NCT04049578 Autism Spectrum Disorder PHASE1 TERMINATED 2020-05-06 Southwest Autism Research & Re... More >>source Center, Phoenix, Arizona, 85006, United States|Richmond Behavioral Associates, Staten Island, New York, 10312, United States|University Hospitals Cleveland Medical Center; Division of Child and Adolescent Psychiatry, Cleveland, Ohio, 44106, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Red Oak Psychiatry Associates, PA, Houston, Texas, 77090, United States Less <<
NCT03912350 Autism Spectrum Disorder PHASE1 WITHDRAWN 2022-10-13 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.44mL

0.49mL

0.24mL

12.20mL

2.44mL

1.22mL

24.40mL

4.88mL

2.44mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories